GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » Cost of Goods Sold

Avricore Health (Avricore Health) Cost of Goods Sold : $1.39 Mil (TTM As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Avricore Health Cost of Goods Sold?

Avricore Health's cost of goods sold for the three months ended in Dec. 2023 was $0.64 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Dec. 2023 was $1.39 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Avricore Health's Gross Margin % for the three months ended in Dec. 2023 was 36.97%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Avricore Health's Inventory Turnover for the three months ended in Dec. 2023 was 79.50.


Avricore Health Cost of Goods Sold Historical Data

The historical data trend for Avricore Health's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Cost of Goods Sold Chart

Avricore Health Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cost of Goods Sold
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.07 0.97 1.70

Avricore Health Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Cost of Goods Sold Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.60 0.24 0.51 0.64

Avricore Health Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

Cost of Goods Sold for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.39 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avricore Health  (OTCPK:AVCRF) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Avricore Health's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=(Revenue - Cost of Goods Sold) / Revenue
=(1.009 - 0.636) / 1.009
=36.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Avricore Health's Inventory Turnover for the three months ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.


Avricore Health Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Avricore Health's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.


Avricore Health (Avricore Health) Business Description

Traded in Other Exchanges
Address
1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2
Avricore Health Inc is a Canada based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and sale of testing panels.

Avricore Health (Avricore Health) Headlines

From GuruFocus

Emerald Health Therapeutics Expands Strategic Investment in VANC

By Marketwired Marketwired 04-17-2018

Avricore Grants Options

By GlobeNewswire GlobeNewswire 08-11-2022

VANC Pharmaceuticals Inc. Provides Corporate Update

By GlobeNewswire GlobeNewswire 11-02-2018

Avricore Health Announces Lifting of Management Cease Trade Order

By Marketwired Marketwired 06-04-2019

Avricore Health Extends Closing of Placement

By GlobeNewswire GlobeNewswire 07-20-2019